First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants
Clinical trial NCT03919409 · COMPLETED
Trial details
- NCT number
- NCT03919409
- Sponsor
- Taisho Pharmaceutical R&D Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2020-02-11
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.